American Green (American Green) Capital Expenditure : $-0.26 Mil (TTM As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is American Green Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

American Green's cash flow for capital expenditures for the six months ended in Jun. 2023 was $-0.26 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.26 Mil.

American Green Capital Expenditure Historical Data

The historical data trend for American Green's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Green Capital Expenditure Chart

American Green Annual Data

Trend

Jun22

Jun23

Capital Expenditure

-5.83

-0.26

American Green Semi-Annual Data
	Jun22	Jun23
Capital Expenditure	-5.83	-0.26

American Green Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Capital Expenditure for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.26 Mil.

American Green (American Green) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » American Green Inc (OTCPK:ERBB) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

N/A

Address

30 N Gould Street, Suite R, Sheridan, WY, USA, 82801

Website

https://www.americangreen.com

American Green Inc is a technology company in the medical cannabis industry. It is involved in the business of developing a cultivation facility in Phoenix Arizona for medical marijuana and also owns proprietary dispensing machines and all rights to a line of health supplements.